Jeff7575

    • Jeff7575Jeff7575
      ·12-16
      Share your opinion about this news…

      Wall Street’s Lone Nvidia Bear Is Doubling Down on His Call, with High Conviction

      Seaport Research’s negative view of Nvidia’s stock hasn’t panned out thus far, but analyst Jay Goldberg is emphasizing the recommendation as he looks to 2026.
      Wall Street’s Lone Nvidia Bear Is Doubling Down on His Call, with High Conviction
      142Comment
      Report
    • Jeff7575Jeff7575
      ·08-11
      Share your opinion about this news…

      Intel CEO Singled Out by Trump to Visit White House on Monday

      Intel CEO Lip-Bu Tan is set to visit the White House Monday after President Trump called for his removal last week over ties to Chinese businesses, according to people familiar with the matter.Tan is...
      Intel CEO Singled Out by Trump to Visit White House on Monday
      825Comment
      Report
    • Jeff7575Jeff7575
      ·04-11
      Share your opinion about this news…

      US Monthly Producer Prices Decline In March

      US PPI YoY Actual 2.7% (Forecast 3.3%, Previous 3.2%)
      US Monthly Producer Prices Decline In March
      664Comment
      Report
    • Jeff7575Jeff7575
      ·2024-01-04
      Share your opinion about this news…

      U.S. Stocks To Watch: Meta, Cal-Maine Foods, Dyne Therapeutics, Intel, Walgreens, and More

      Stock futures pointed higher Thursday after equities started off the first two trading days of 2024 with losses. Pushing stocks lower were the minutes from the Federal Reserve's meeting from December in which central bank officials said interest-rate cuts were likely in 2024 but they also didn't rule out further rate hikes this year, citing an "unusually elevated degree of uncertainty.". Meta Platforms CEO Mark Zuckerberg sold about $428 million of company stock over the final two months of 2023, according to a regulatory filing. Zuckerberg, who co-founded the parent of Facebook and Instagram, unloaded nearly 1.28 million shares of stock. He sold shares on every trading day between Nov. 1 and the end of the year, according to the filing. Meta shares were rising 0.2% in premarket trading to $345.17. The stock fell 0.5% on Wednesday. It gained 194% last year.Dyne Therapeutics, the clinical stage muscle disease company, said it has begun an underwritten public offering of $175 million of
      U.S. Stocks To Watch: Meta, Cal-Maine Foods, Dyne Therapeutics, Intel, Walgreens, and More
      836Comment
      Report
    • Jeff7575Jeff7575
      ·2023-08-16
      Share your opinion about this news…
      Sorry, this post has been deleted
      842Comment
      Report
       
       
       
       

      Most Discussed